Biofrontera (BFRI) Revenue Growth (1y) (2021 - 2025)
Biofrontera (BFRI) Revenue Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.83 Bn | 32.09 Bn | 1.97 Bn | 2.34% |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | 2.91% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -11.85% |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn | -1.62% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 7.85% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | 42.25% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 14.92% |
| 10 | Biofrontera | 10.78 Mn | 4.37 Mn | 14.09 Mn | 36.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36.16% |
| Sep 30, 2025 | -22.46% |
| Jun 30, 2025 | 15.19% |
| Mar 31, 2025 | 8.54% |
| Dec 31, 2024 | 18.53% |
| Sep 30, 2024 | 1.30% |
| Jun 30, 2024 | 34.05% |
| Mar 31, 2024 | -9.40% |
| Dec 31, 2023 | 4.46% |
| Sep 30, 2023 | 105.83% |
| Jun 30, 2023 | 31.21% |
| Mar 31, 2023 | -10.44% |
| Dec 31, 2022 | 168.19% |
| Sep 30, 2022 | -0.28% |
| Jun 30, 2022 | -23.88% |
| Mar 31, 2022 | 105.54% |
| Dec 31, 2021 | -273.53% |
| Sep 30, 2021 | 33.27% |